CTNM Cash From Investing

Annual CFI

-$69.74 M
-$4.17 M-6.36%

December 31, 2024


Summary


Performance

CTNM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTNMcash flowmetrics:

Quarterly CFI

-$9.39 M
+$20.80 M+68.90%

December 31, 2024


Summary


Performance

CTNM Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTNMcash flowmetrics:

TTM CFI

-$69.74 M
-$18.42 M-35.89%

December 31, 2024


Summary


Performance

CTNM TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCTNMcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

CTNM Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-6.4%+68.9%-35.9%
3 y3 years-7.3%--
5 y5 years-7.3%--

CTNM Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-412.7%at low-200.3%+78.9%-845.5%+6.5%
5 y5-year-412.7%at low-200.3%+78.9%-845.5%+6.5%
alltimeall time-412.7%at low-200.3%+78.9%-845.5%+6.5%

Contineum Therapeutics Class A Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
-$69.74 M(+6.4%)
-$9.39 M(-68.9%)
-$69.74 M(+35.9%)
Sep 2024
-
-$30.18 M(-22.4%)
-$51.32 M(-15.4%)
Jun 2024
-
-$38.90 M(-545.5%)
-$60.63 M(-8.4%)
Mar 2024
-
$8.73 M(-3.3%)
-$66.19 M(+1.0%)
Dec 2023
-$65.57 M
$9.03 M(-122.9%)
-$65.57 M(-12.1%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$39.50 M(-11.2%)
-$74.60 M(+112.5%)
Jun 2023
-
-$44.46 M(-575.2%)
-$35.10 M(-475.2%)
Mar 2023
-
$9.36 M
$9.36 M
Dec 2022
$22.30 M(-134.3%)
-
-
Dec 2021
-$64.97 M
-
-

FAQ

  • What is Contineum Therapeutics Class A annual cash flow from investing activities?
  • What is the all time high annual CFI for Contineum Therapeutics Class A?
  • What is Contineum Therapeutics Class A annual CFI year-on-year change?
  • What is Contineum Therapeutics Class A quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Contineum Therapeutics Class A?
  • What is Contineum Therapeutics Class A quarterly CFI year-on-year change?
  • What is Contineum Therapeutics Class A TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Contineum Therapeutics Class A?
  • What is Contineum Therapeutics Class A TTM CFI year-on-year change?

What is Contineum Therapeutics Class A annual cash flow from investing activities?

The current annual CFI of CTNM is -$69.74 M

What is the all time high annual CFI for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high annual cash flow from investing activities is $22.30 M

What is Contineum Therapeutics Class A annual CFI year-on-year change?

Over the past year, CTNM annual cash flow from investing activities has changed by -$4.17 M (-6.36%)

What is Contineum Therapeutics Class A quarterly cash flow from investing activities?

The current quarterly CFI of CTNM is -$9.39 M

What is the all time high quarterly CFI for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high quarterly cash flow from investing activities is $9.36 M

What is Contineum Therapeutics Class A quarterly CFI year-on-year change?

Over the past year, CTNM quarterly cash flow from investing activities has changed by +$20.80 M (+68.90%)

What is Contineum Therapeutics Class A TTM cash flow from investing activities?

The current TTM CFI of CTNM is -$69.74 M

What is the all time high TTM CFI for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high TTM cash flow from investing activities is $9.36 M

What is Contineum Therapeutics Class A TTM CFI year-on-year change?

Over the past year, CTNM TTM cash flow from investing activities has changed by -$18.42 M (-35.89%)